Cell-derived biomimetic nanomedicines: Emerging theranostic platforms for precision management of atherosclerosis
Theranostics · 2026
DOI: 10.7150/thno.133733 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, 2026. Verfasst von Xingji Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Jinling Hospital, The First School of Clinical Medicine, Southern Medical University, Nanjing, Jiangsu 210008, China. Hauptthemen laut MEDLINE: Theranostic Nanomedicine, Atherosclerosis, Biomimetics, Biomimetic Materials. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Jinling Hospital, The First School of Clinical Medicine, Southern Medical University, Nanjing, Jiangsu 210008, China.
- Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu 210008, China.
- Department of Radiology, Jinling Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210008, China.
Zitieren
APA
Liu, X., Wang, Z., Lu, J., Sheng, J., & Zhang, L. (2026). Cell-derived biomimetic nanomedicines: Emerging theranostic platforms for precision management of atherosclerosis. Theranostics. https://doi.org/10.7150/thno.133733
Vancouver
Liu X, Wang Z, Lu J, Sheng J, Zhang L. Cell-derived biomimetic nanomedicines: Emerging theranostic platforms for precision management of atherosclerosis. Theranostics. 2026. doi:10.7150/thno.133733
BibTeX
@article{Liu2026,
author = {Liu, Xingji and Wang, Zhiyue and Lu, Jiaqi and Sheng, Jie and Zhang, Longjiang},
title = {Cell-derived biomimetic nanomedicines: Emerging theranostic platforms for precision management of atherosclerosis},
journal = {Theranostics},
year = {2026},
doi = {10.7150/thno.133733}
}
EUVIMED